Systemic immune-inflammation index as a prognostic marker in HER2-positive breast cancer patients undergoing trastuzumab therapy

Systemic immune-inflammation index as a prognostic marker in HER2-positive breast cancer patients undergoing trastuzumab therapy

Abstract The prognostic value of SII (Systemic Immune-Inflammation Index) in HER-2-positive breast cancer (BC) patients, regardless of whether they receive trastuzumab treatment, and its potential value to distinguish patients who may benefit from trastuzumab therapy, warrant further investigation....

Full description

Bibliographic Details
Main Authors: Jian Pang, Nianhua Ding, Nana Yin, Zhi Xiao
Format: Article
Language:English
Published: Nature Portfolio 2024-03-01
Series:Scientific Reports
Subjects:
Breast cancer
HER-2-positive
Trastuzumab
Systemic immune-inflammatory index (SII)
Prognosis
Online Access:https://doi.org/10.1038/s41598-024-57343-0

Similar Items

Similar Items